Suppr超能文献

[测定凝血酶原片段F1+2以监测苯丙香豆素的抗凝效果]

[Measurement of prothrombin fragment F1+2 for monitoring the anticoagulant effect of phenprocoumon].

作者信息

Bruhn H D, Zurborn K H

机构信息

I. Medizinische Universitätsklinik Kiel.

出版信息

Dtsch Med Wochenschr. 1993 Jul 2;118(26):967-70. doi: 10.1055/s-2008-1059413.

Abstract

It was the aim of this study to ascertain whether the plasma level of prothrombin fragment F1+2 is a suitable indicator of the anticoagulant effect of coumarin derivatives. The F1+2 levels were measured in 164 patients (100 women, 64 men; mean age 63.3 [34-83] years) in whom stable anticoagulation had been achieved with phenprocoumon, comparing the results with those obtained in healthy subjects (28 women, 19 men; mean age 54.6 [25-72] years) without anticoagulation. There was a significant reduction (P < 0.0005) in F1+2 plasma levels with oral anticoagulation (0.45 + 0.23 vs. 0.67 + 0.32 nmol/l). Even on a low degree of anticoagulation (international normalized ratio [INR] < 2.0) the F1+2 value was reduced to within the normal range (0.32-1.2 nmol/l). These results indicate that changes in the plasma level of prothrombin fragment F1+2 are directly dependent on the degree of oral anticoagulation and that this measure seems suitable for the monitoring of the anticoagulant effect. This is also true for oral anticoagulation of mild degree (INR < 2.0) in which the effect cannot be satisfactorily measured by the thromboplastin time (Quick test).

摘要

本研究的目的是确定凝血酶原片段F1+2的血浆水平是否是香豆素衍生物抗凝效果的合适指标。对164例已用苯丙香豆素实现稳定抗凝的患者(100名女性,64名男性;平均年龄63.3[34 - 83]岁)测定F1+2水平,并将结果与未接受抗凝的健康受试者(28名女性,19名男性;平均年龄54.6[25 - 72]岁)的结果进行比较。口服抗凝治疗后,F1+2血浆水平显著降低(P < 0.0005)(0.45 + 0.23对0.67 + 0.32 nmol/L)。即使在低抗凝程度(国际标准化比值[INR]<2.0)下,F1+2值也降至正常范围内(0.32 - 1.2 nmol/L)。这些结果表明,凝血酶原片段F1+2的血浆水平变化直接取决于口服抗凝的程度,并且该指标似乎适用于监测抗凝效果。对于轻度口服抗凝(INR<2.0)也是如此,在这种情况下,无法通过凝血活酶时间(Quick试验)令人满意地测定其效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验